Balchem Corp
NASDAQ:BCPC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
137.06
183.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balchem Corp
Balchem Corp
Additional Paid In Capital
Balchem Corp
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Balchem Corp
NASDAQ:BCPC
|
Additional Paid In Capital
$168.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Additional Paid In Capital
$19.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
39%
|
CAGR 10-Years
65%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Additional Paid In Capital
$48.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Additional Paid In Capital
$7.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Additional Paid In Capital
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Balchem Corp
Glance View
In the world of specialty chemicals, Balchem Corp. has quietly but powerfully carved a distinguished niche. Founded in 1967, this company has grown from its humble beginnings to become a major player by focusing on innovation and strategic expansion. Balchem operates through three key segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Each segment speaks to a broader narrative of how the company intertwines science with industry needs. At the heart of its operations is the use of advanced encapsulation technology, which involves coating sensitive ingredients to enhance their stability and effectiveness. This core competency is particularly crucial in the nutrition categories, where the company's products improve the shelf life and efficacy of vitamins, minerals, and supplements. The company’s revenue model is built on providing tailored solutions that address specific challenges within various industries. In the Human Nutrition & Health sector, Balchem supplies nutrient delivery systems to some of the most well-known dietary supplement brands, essentially helping them refine product quality and meet consumer expectations for efficacy. Meanwhile, in the Animal Nutrition & Health division, Balchem develops solutions that help improve the performance and health of livestock, which is harmoniously aligned with the global push towards more sustainable agricultural practices. The Specialty Products division rounds out Balchem’s portfolio, catering to industrial markets, including oil and gas, by providing advanced chemical solutions. Through these segments, Balchem generates income by continually expanding its portfolio of patented technologies and forming long-term partnerships with clients across the globe, ensuring its growth in an ever-evolving market.
See Also
What is Balchem Corp's Additional Paid In Capital?
Additional Paid In Capital
168.2m
USD
Based on the financial report for Sep 30, 2024, Balchem Corp's Additional Paid In Capital amounts to 168.2m USD.
What is Balchem Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%
Over the last year, the Additional Paid In Capital growth was 19%. The average annual Additional Paid In Capital growth rates for Balchem Corp have been -1% over the past three years , -1% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
